http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113740476-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_398b13b3030fd7dd247eaf1d2006aa58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8872
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88
filingDate 2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a6b4d8033eb59d9f8c7f0c32537d06e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d918cb2205150e3a38c098b842d7838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e0558ccecdb27e3c7f00315cd75aee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f001c0d8e226e38d6908fde09435965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc3c416c95326ac8711341ad1b6e061d
publicationDate 2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113740476-A
titleOfInvention Method for detecting content of impurity L-2-aminobutanamide hydrochloride in brivaracetam drug
abstract The invention relates to a method for detecting the content of impurity L-2-aminobutanamide hydrochloride in a brivaracetam drug. The method for detecting the impurity L-2-aminobutanamide hydrochloride in the brivaracetam specifically comprises the following steps of: (1) preparing a test solution; (2) preparing a reference substance solution; (3) respectively sucking the test solution and the reference solution, injecting into a high performance liquid chromatograph, wherein the chromatographic conditions are as follows: a chromatographic column: octadecylsilane chemically bonded silica is used as a filling agent; mobile phase: the composite material consists of a phase A and a phase B, wherein the phase A is a sodium octane sulfonate solution, and the phase B is acetonitrile. The detection method can accurately detect the content of the L-2-aminobutanamide hydrochloride in the brivaracetam drug, effectively separate the chromatographic peak of the brivaracetam and the impurity L-2-aminobutanamide hydrochloride, improve the quality of the brivaracetam drug and have wide application prospect.
priorityDate 2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161700150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420122536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100533331
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18489
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36080
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409203328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4217966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449300370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453905956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11961924
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23669624

Total number of triples: 41.